Keyphrases
Amikacin
33%
Antibiotic Combination
16%
Antibiotic Susceptibility Pattern
100%
Antibiotic Use
16%
Antibiotics
33%
Bacterial Isolates
100%
Baumannii
16%
Carbapenems
50%
Central Hospitals
33%
Colistin
33%
Common Pathogens
16%
Cumulative Antibiogram
33%
Current Guidelines
16%
Empirical Therapy
16%
Enterobacter
16%
Gentamicin
16%
Gram-negative Pathogens
16%
Health Systems
16%
Intensive Care Unit
83%
Intensive Care Unit Patients
100%
Klebsiella Pneumoniae (K. pneumoniae)
50%
Leading Causes of Death
16%
Linezolid
16%
Local Setting
16%
Lower Respiratory Tract Infection
100%
Meropenem
16%
Namibia
100%
Patient Management
16%
Pseudomonas Aeruginosa (P. aeruginosa)
16%
Public Health Risk
16%
Referral Hospital
100%
Rifampicin
16%
Staphylococcus Aureus
16%
Stenotrophomonas Maltophilia
16%
Sub-Saharan African Countries
16%
Susceptibility Pattern
33%
Teicoplanin
16%
Tigecycline
33%
Vancomycin
16%
Windhoek
33%
Medicine and Dentistry
Amikacin
33%
Antibiogram
100%
Antibiotics
66%
Carbapenem Derivative
50%
Colistimethate
33%
Cross Sectional Study
16%
Enterobacter
16%
Gentamicin
16%
Health System
16%
Intensive Care Unit
100%
Linezolid
16%
Lower Respiratory Tract Infection
100%
Meropenem
16%
Pathogen
66%
Patient Care
16%
Patient Referral
100%
Pseudomonas aeruginosa
16%
Public Health
16%
Rifampicin
16%
Staphylococcus Aureus
16%
Teicoplanin
16%
Tigecycline
33%
Vancomycin
16%
Pharmacology, Toxicology and Pharmaceutical Science
Amikacin
33%
Antibiotic Agent
50%
Antibiotics
100%
Carbapenem Derivative
50%
Colistimethate
33%
Cross-Sectional Study
16%
Enterobacter
16%
Gentamicin
16%
Infectious Agent
66%
Linezolid
16%
Lower Respiratory Tract Infection
100%
Meropenem
16%
Pseudomonas aeruginosa
16%
Rifampicin
16%
Staphylococcus Aureus
16%
Teicoplanin
16%
Tigecycline
33%
Vancomycin
16%